Diagnostic accuracy and clinical usefulness of erythrocyte creatine content to predict the improvement of anaemia in patients receiving maintenance haemodialysis

Table 2 Factors related to the ^aimprovement of anaemia

			95% Confidence Interval		P Value
	Odds ratio	Chi-square	Lower	Upper	P Value
Erythrocyte creatine content (μmol/gHb)	48.82	18.72	8.39	284.17	0.0001
ESA dose (units/week)	1.00	4.45	0.99	1.01	0.04
Reticulocyte (%)	1.05	0.63	0.93	1.18	0.43
Haptoglobin (g/dL)	1.01	4.63	1.00	1.03	0.031
Haemoglobin at baseline (g/dL)	0.41	5.73	0.19	0.85	0.017
Serum calcium (mg/dL)	0.98	0.001	0.22	4.24	0.97
Intact parathyroid hormone (pg/mL)	1.00	0.03	0.99	1.01	0.87
Transferrin saturation (%)	1.01	0.14	0.96	1.07	0.71
Serum ferritin (ng/mL)	1.00	0.02	0.99	1.01	0.98

ESA erythropoiesis stimulating agent
^aImprovement of anaemia ≥ 0.8 g/dL change in haemoglobin from baseline to 3 months

ISSN: 1471-2369